Physician
Cardiology
Dr. Donald L. Lappe, MD
|
|
Give Review
Donald Lappe works in the field of Cardiology. He attended Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical university. Johns Hopkins University School of Medicine is ranked 3 in research and 29 in primary care medicine He received 1 awards: "Fellow (FACC)". Donald Lappe is a published doctor. He published 46 publications, including: 'Cyclophosphamide in cardiac transplant recipients with frequent rejection: a six-year retrospective review.' Donald L. Lappe accepts Medicare.
Publications
- Impact of Testosterone Replacement Therapy on Myocardial Infarction, Stroke, and Death in Men With Low Testosterone Concentrations in an Integrated Health Care System.
- Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High-Risk Patients With Diabetes: The FACTOR-64 Randomized Clin...
- Coronary Artery Plaque Volume and Obesity in Patients with Diabetes: The Factor-64 Study.
- Randomized cross-over trial of short-term water-only fasting: Metabolic and cardiovascular consequences.
- Atrial fibrillation ablation patients have long-term stroke rates similar to patients without Atrial fibrillation regardless of CHADS2 score.
- Increasing time between first diagnosis of Atrial fibrillation and catheter ablation adversely affects long-term outcomes.
- Intracardiac ultrasound for esophageal anatomic assessment and localization during left Atrial ablation for Atrial fibrillation.
- Ranolazine Reduces Ventricular Tachycardia Burden and ICD Shocks in Patients with Drug-Refractory ICD Shocks.
- Atrial Fibrillation Hospitalization Is Not Increased with Short-Term Elevations in Exposure to Fine Particulate Air Pollution.
- Genome-wide significance and replication of the chromosome 12p11.22 locus near the PTHLH gene for peripartum Cardiomyopathy.
- Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular Disease: Dependent or independent risk factors?
- Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with Coronary disease and a normal comparison population.
- Trends in early and late morality in patients undergoing Coronary catheterization for myocardial infarction: Implications on observation periods and risk factors to de...
- Patients Treated with Catheter Ablation for Atrial Fibrillation Have Long-Term Rates of Death, Stroke, and Dementia Similar to Patients Without Atrial Fibrillation.
- A Strategy of Rapid Cardioversion Minimizes the Significance of Early Recurrent Atrial TachyArrhythmias After Ablation for Atrial Fibrillation.
- Association of vitamin D levels with incident depression among a general cardiovascular population.
- Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia.
- Long-term clinical efficacy and risk of catheter ablation for Atrial fibrillation in octogenarians.
- Warfarin is not needed in low-risk patients following Atrial fibrillation ablation procedures.
- Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors.
- Exceptional mortality prediction by risk scores from common laboratory tests.
- Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently.
- Superior predictive ability for death of a basic metabolic profile risk score.
- Relation of bisphosphonate therapies and risk of developing Atrial fibrillation.
- Hyperglycemia predicts mortality after CABG: postoperative hyperglycemia predicts dramatic increases in mortality after Coronary artery bypass graft surgery.
- Frequency of helicobacter pylori seropositivity and C-reactive protein increase in atrial fibrillation in patients undergoing Coronary angiography.
- Incremental survival benefit with adherence to standardized Heart failure core measures: a performance evaluation study of 2958 patients.
- Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel Coronary a...
- Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: res...
- Comparison of effects of high (80 mg) versus low (20 mg) dose of simvastatin on C-reactive protein and lipoproteins in patients with angiographic evidence of Coronary ...
- Temporary esophageal stenting allows healing of esophageal perforations following Atrial fibrillation ablation procedures.
- Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program.
- Preoperative use of enoxaparin compared with unfractionated heparin increases the incidence of re-exploration for postoperative bleeding after open-Heart surgery in pa...
- Effects of statins on six-month survival and clinical restenosis frequency after Coronary stent deployment.
- Repeated measurement of the intermountain risk score enhances prognostication for mortality.
- Continuous measurement of tissue blood flow by laser-Doppler spectroscopy.
- Two-dimensional echocardiographic diagnosis of left Atrial myxoma.
- Isolated drainage of the superior vena cava into the left atrium in a 52-year-old man: a rare Congenital malformation in the adult presenting with cyanosis, polycythem...
- Effect of pacing-induced tachycardia and myocardial ischemia on ventricular pressure-velocity relationships in man.
- Cyclophosphamide as an alternative to azathioprine in cardiac transplant recipients with suspected azathioprine-induced hepatotoxicity.
- Cyclophosphamide in cardiac transplant recipients with frequent rejection: a six-year retrospective review.
- Femoral arterial puncture management after percutaneous Coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and ...
- Warfarin knowledge in patients with Atrial fibrillation: implications for safety, efficacy, and education strategies.
- Nurse managers as consultants.
- Coronary artery disease screening using Coronary computed tomography angiography--reply.
Schools
Johns Hopkins University School Of Medicine
Mary Hitchcock Meml Hospital
Strong Memorial Hospital
Procedures Preformed
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Cardiac Myocardial Perfusion Imaging
- Cardioversion, Elective
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Ectasia
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Johns Hopkins University -
University of Rochester -
Dartmouth-Hitchcock Medical Center -
Johns Hopkins University School of Medicine
Hospital
-
Intermountain Medical Center
Drug Facts
| NPI NUMBER | 1669440277 | |
| NPPES Provider LastName | LAPPE | |
| NPPES Provider FirstName | DONALD | |
| NPPES Provider ZIPCode | 841076767 | |
| NPPES Provider State | UT | |
| Specialty Description | Cardiology | |
| Total Claim Count | 1039.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1669440277 |
| Last Name Of The Provider | LAPPE |
| First Name Of The Provider | DONALD |
| View All |
Similar Doctors
|
|
Dr. Frank G. Yanowitz, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Imran Zubair, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohamed H. Hamdan, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Rodolphe Ruffy, MD |
|
|
Dr. Jack H. Morshedzadeh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael F. Sheets, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Travis S. Wall, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peyman Nejatbakhsh Azadani, MD |
|
|
Dr. Kevin J. Whitehead, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Rani R. Mulamalla |